Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15.
Lehmann-Che J, Hamy AS, Porcher R, Barritault M, Bouhidel F, Habuellelah H, Leman-Detours S, de Roquancourt A, Cahen-Doidy L, Bourstyn E, de Cremoux P, de Bazelaire C, Albiter M, Giacchetti S, Cuvier C, Janin A, Espié M, de Thé H, Bertheau P.
Lehmann-Che J, et al. Among authors: hamy as.
Breast Cancer Res. 2013 May 11;15(3):R37. doi: 10.1186/bcr3421.
Breast Cancer Res. 2013.
PMID: 23663520
Free PMC article.